United Therapeutics | UTHR - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
Amarin USD 20.81M 13K 2025-12
Ardelyx USD 244.35M 1.38M 2025-12
Baxter International USD 516.45M 2.17M 2026-03
Bayer EUR 982.42M 0 2025-12
BioCryst Pharmaceuticals USD 213.06M 2.54M 2025-12
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 193.27M 969K 2026-03
Emergent BioSolutions USD 100K 0 2023-06
Esperion Therapeutics USD 245.22M 39.79M 2025-12
Gilead Sciences USD 1.24B 1000K 2026-03
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
Halozyme Therapeutics USD 118.52M 741K 2026-03
Insmed USD 216.52M 2.27M 2026-03
Ionis Pharmaceuticals USD 165.9M 3.93M 2026-03
J&J USD 2.41B 1.74M 2025-12
Lexicon Pharmaceuticals USD 363.47M 67K 2025-12
Moderna USD 391M 2M 2025-09
Omeros USD 611K 17K 2023-12
Pfizer USD 5.7B 13M 2026-03
PTC Therapeutics USD 81.47M 1.54M 2025-12
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Sarepta Therapeutics USD 105.57M 607K 2026-03
Teva Pharmaceutical Industries USD 1.16B 16.72M 2026-03
United Therapeutics USD 42.16M 1.49M 2026-03
Vertex Pharmaceuticals USD 254.2M 200K 2026-03